Ebtcs (Eastside Behavioral Treatment and Consulting Services)

The Evidence Based Treatment Centers of Seattle (EBTCS), PLLC is a network of specialty mental health centers united by a central mission: to deliver state-of-the-art, evidence-based psychological treatments with genuine compassion and care. We believe it is our responsibility to stay up to date with current research and advances in our field, so that when people entrust us with their care, we can confidently say that we are providing treatments that have the best science behind them. We also believe that people learn and grow best when they are in an environment of genuine compassion and support. Science and compassion: it's a simple formula and one that is at the core of everything we do.

Plymouth Healing Communities is a nonprofit organization based in Seattle, WA, dedicated to breaking the cycle of hospitalization and homelessness for individuals living with mental illness. The organization achieves its mission through small-scale housing, companionship, community partnerships, and mission-driven property management. Since its inception, Plymouth Healing Communities has provided over 164,000 sheltered days, fostering a healing community that supports individuals in rebuilding their lives and rekindling hope. By encouraging community involvement, the organization invites everyone to play a role in addressing the homelessness crisis in Seattle. Generated from the website

Omeros Corp, based in Seattle, WA, is a leading biopharmaceutical company known for its innovative and cutting-edge science. With a focus on developing life-saving therapies for patients with challenging diseases and disorders, Omeros boasts a deep and diverse pipeline of first-in-class drugs targeting previously untapped receptors and enzymes. The company prides itself on its world-class team of talented, passionate, and collaborative individuals from diverse backgrounds, working together to advance scientific breakthroughs and provide hope to patients and their families. Omeros is committed to letting science lead the way in delivering wholly new classes of therapeutics to address significant unmet medical needs. Generated from the website